Metal-On-Metal Hip Post-market Studies Behind Schedule, NEJM Article Highlights

Delays in getting FDA-ordered surveillance studies up and running for hip implants should be addressed at an advisory panel this week, researchers from the Pew Health Group and Cornell argue.

More from Regulation

More from Policy & Regulation